共 160 条
[1]
Al-Sarraj S(2011)p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS Acta Neuropathol 122 691-702
[2]
King A(2007)TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease Ann Neurol 61 435-445
[3]
Troakes C(2009)Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies Acta Neuropathol 117 125-136
[4]
Amador-Ortiz C(2005)Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation J Neurochem 94 192-203
[5]
Lin WL(2007)Neuropathologic heterogeneity in HDDD1: a familial frontotemporal lobar degeneration with ubiquitin-positive inclusions and progranulin mutation Alzheimer Dis Assoc Disord 21 1-7
[6]
Ahmed Z(2012)Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Brain 135 765-783
[7]
Arai T(1991)Neuropathological staging of Alzheimer-related changes Acta Neuropathol 82 239-259
[8]
Mackenzie IR(2012)Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion Acta Neuropathol 123 825-839
[9]
Hasegawa M(2007)Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 5-22
[10]
Babu JR(2001)Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation Nat Cell Biol 3 740-744